Pfizer May Sell Animal Health Assets

According to a news article from Bloomberg, multiple parties expressed interest in the animal products, which the marketplace has viewed as ‘desirable,’ chief financial officer Frank D’Amelio said yesterday.

“In the US, we are actively engaged in negotiations in animal health,” Mr D’Amelio told Bloomberg. “There are parties that have expressed interest.”

Mr D’Amelio declined to elaborate on the bidding process. When Pfizer completes its purchase of Wyeth, it will have the world’s biggest animal health business, with about $4 billion in annual revenue, the company said.

Pfizer has said it may have to divest some of its animal assets. The company is unlikely to divest products with more than $400 million in annual revenue.

Sign up for our
regular news updates

Related news items:

•    Smithfield Sees Profits Return
•    First Trivalent Swine Flu Vaccine with H1N2 Launched by Merial
•    AgFeed Announces Record Revenues
•    Irish Pig Herds Declared Practically Aujeszky-free
•    Pork Commentary: Cash Hog Prices Continue to Surge

Related News Categories: Pig Health, Company/Products

Sign up for our
regular news updates

More of the latest Pig Industry News

•   UK Pig Industry Will Strive to Be Greener
•   Profitable Hog Prices Projected in Second Quarter
•   National Hog Price Weak to Stable
•   Smithfield Sees Profits Return
•   Poultry Loan Guidance Expanded for Pork Operations
•   First Trivalent Swine Flu Vaccine with H1N2 Launched by Merial
•   Livestock Feeding and Crop Management Strategies
•   CME: January Pork Exports Down in Several Markets
•   Sharing of Pig Handling Tips and Techniques
•   PSA: Poor Harvest Year May Have Altered Corn Quality